Related Experiment Video
Updated: May 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Paracetamol in Pregnancy: Uncertain Evidence, Certain Consequences
David J Tunnicliffe1,2, Miranda Cumpston3, Debra Kennedy4,5
1School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Abstract:
Autism diagnoses have increased over the past decade, prompting debate on potential causes. In September 2025, US President Donald Trump claimed that paracetamol is a 'big factor' in autism, citing a systematic review based solely on observational studies. The review's selective reporting, methodological flaws (including applying an environmental health rather than evidence-based medicine framework) and lack of causal evidence provided weak justifications for its conclusions and have fuelled public confusion about paracetamol safety in pregnancy. This article critically appraises the review and examines how scientific uncertainty can be manipulated and amplified within broader public health domains.
Related Concept Videos
Teratogenicity
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Toxicity: Dose-Dependent Reactions